Sleep Disorders

What sleep disorders are common in older adults and what are the associated risk factors and correlates?

All in a good night’s sleep? Researchers performed a pharmacovigilance study of second-generation antipsychotics and mood stabilizers as the suspected agent of psychiatric adverse drug reactions (insomnia and suicide/ideation/behavior/death).

Pain can have a substantial impact on sleep quality and quality of life.

New research suggests deliberate control of breathing could help regulate autonomic function in patients who have insomnia.

A hypnotic might be a good option for augmenting depression treatment, but which hypnotic has the best evidence for efficacy?

In this custom video series, Debra Stultz, MD, and Haramandeep Singh, MD, share advice for community-based psychiatrists on the management of narcolepsy.

In this custom video series, sleep specialists discuss common unmet needs and challenges when treating patients with narcolepsy.

In this custom video series, Haramandeep Singh, MD, and Debra Stultz, MD, discuss the roles and responsibilities of sleep specialists, neurologists, and psychiatrists in the management of narcolepsy.

In this custom video series, experts in sleep medicine discuss patient factors and symptoms they consider when selecting optimal treatment regimens for patients with narcolepsy.

In this custom video series, Debra Stultz, MD, comments on common psychiatric comorbidities seen with narcolepsy and the impact on a patient’s quality of life.

In this custom video series, Haramandeep Singh, MD, and Debra Stultz, MD, discuss a case involving a 23-year-old man with schizoaffective disorder and newly diagnosed narcolepsy.

In this custom video series, Debra Stultz, MD, leads the discussion on the use of pitolisant as initial therapy for a patient newly diagnosed with narcolepsy and cataplexy.

In this custom video series, experts in sleep medicine provide insight on ways cataplexy can present in patients with narcolepsy.

In this custom video series, Haramandeep Singh, MD, and Debra Stultz, MD, discuss a case involving a 20-year-old woman newly diagnosed with narcolepsy and cataplexy, initial impressions, and appropriate provider referral.

This hypersomnia treatment just received an extended approval for cataplexy and excessive daytime sleepiness.

A brain-based perspective could explain how and why psychotherapy leads to enduring change.

Sedation may not always be desirable, but it is difficult to avoid in psychiatry. Some of the most sedating medications are discussed.

Key considerations for healthcare providers seeking to manage their patients’ insomnia.

This investigational dual orexin receptor antagonist improved sleep overnight and daytime functioning.

The key to better sleep? Stabilizing blood sugar.

Nightmare disorder can produce emotional manifestations of fear, anger, and sadness. Here are 7 reasons parasomnias can challenge even the most astute diagnostician.

If approved, this formulation of sodium oxybate will be the first once-nightly oxybate treatment for daytime sleepiness.

The stress and anxiety of the COVID-19 pandemic might be interfering with sleep patterns.

How cost-effective is fully automated digital cognitive behavioral therapy (CBT) intervention for insomnia?

The International Project Team Lead for the lemborexant clinical development program shares insights from their presentations at the Virtual SLEEP 2020 Meeting.